ACP addresses systemic racism, commits to being an antiracist organization
ACP has released a new policy statement examining racism and discrimination in U.S. society and their role as a social determinant of health, offering recommendations to address and mitigate these issues, including in law enforcement, and committing to building and expanding on existing policies on racial and ethnic disparities in health care and on hate crimes as a public health issue. In addition, the policy paper states that ACP is committed to being an antiracist organization.
The policy paper was written by ACP's Health and Public Policy Committee, which addresses issues that affect the health care of the U.S. public and the practice of internal medicine and its subspecialties. The authors reviewed available studies, reports, and surveys related to racism, discrimination, and law enforcement violence published between 1990 and 2020, as well as relevant news articles, policy documents, websites, and other sources. Recommendations were based on reviewed literature and input from ACP's Board of Regents; Diversity, Equity, and Inclusion Subcommittee; and Ethics, Professionalism and Human Rights Committee. The policy paper, as well as its related recommendations, was reviewed and approved by the Board of Regents on June 16. It was published by Annals of Internal Medicine on June 19 and is freely available.
New ACP resources on primary care reopening and recovery available
ACP recently published new clinical and public policy guidance on “Partial Resumption of Economic, Health Care and Other Activities While Mitigating COVID-19 Risk and Expanding System Capacity.” In support of ACP's recommendations, “COVID-19: An ACP Physician's Guide and Resources,” includes practical, downloadable resources, such as innovative staffing models and a COVID-19 testing strategy for practices and FAQs and an infographic for patients, to help ambulatory practices safely resume care.
Annals of Internal Medicine migrates its website to new publishing platform
Annals of Internal Medicine's revamped website, now on Atypon's Literatum publishing platform, offers a new streamlined design, advanced search functionality, and improved navigation, while continuing to feature the same practice-enriching content that readers expect from Annals. The new website delivers all of the highly regarded Annals of Internal Medicine content, including research articles, clinical guidelines and commentary, podcasts, and CME courses. Moving to the Atypon platform enables the journal to dynamically generate user-specific content to deepen user engagement.
2020 teaching scholarships, junior investigator awards announced
The Herbert S. Waxman Chief Resident Teaching Scholarships recognize outstanding chief medical residents and provide them an opportunity to assist teaching popular workshops under the guidance and mentorship of expert faculty in the Clinical Skills Center at ACP's annual scientific meeting. ACP congratulates this year's winners: Jeffery Gray, MD, ACP Resident/Fellow Member, Bethesda, Md.; Benjamin Hayes, MD, ACP Resident/Fellow Member, Lawrenceville, Ga.; Vincent Kang, DO, ACP Resident/Fellow Member, Columbus; Henry Lew, MD, ACP Resident/Fellow Member, Honolulu; Sarah E. Schall, MD, ACP Member, San Antonio; and Sarah Steinkruger, MD, ACP Resident/Fellow Member, Seattle.
Annals' Junior Investigator Recognition Awards are presented annually to the most outstanding article by a first author who is in an internal medicine residency program or a general medicine or internal medicine subspecialty fellowship program. The 2020 recipients are Anna Brand, MD, and David Levine, MD, MPH, MA. Dr. Brand is recognized for the article “Medical Graphic Narratives to Improve Patient Comprehension and Periprocedural Anxiety Before Coronary Angiography and Percutaneous Coronary Intervention,” published April 9, 2019. Dr. Levine is recognized for the article “Hospital-Level Care at Home for Acutely Ill Adults,” published Dec. 17, 2019.
ICYMI: Highlights from ACP Internist Weekly
L-thyroxine did not improve symptoms or tiredness in older patients with subclinical hypothyroidism. In a randomized placebo-controlled trial, those treated with thyroid medication instead of placebo did not experience significantly greater improvement in symptoms or quality of life over one year, regardless of the severity of their pretreatment symptoms. The study was published May 5 by Annals of Internal Medicine and summarized in the May 5 ACP Internist Weekly.